Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tanimilast (CHF-6001) is a novel, potent and selective phosphodiesterase 4 inhibitor with an IC 50 value of 0.026 ± 0.006 nM.Tanimilast has potent anti-inflammatory activity and is indicated for topical use in the lungs.Tanimilast was used in the study of obstructive lung disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 280.00 | |
5 mg | In stock | $ 689.00 | |
10 mg | In stock | $ 983.00 | |
25 mg | In stock | $ 1,460.00 | |
50 mg | In stock | $ 1,970.00 | |
100 mg | In stock | $ 2,650.00 |
Description | Tanimilast (CHF-6001) is a novel, potent and selective phosphodiesterase 4 inhibitor with an IC 50 value of 0.026 ± 0.006 nM.Tanimilast has potent anti-inflammatory activity and is indicated for topical use in the lungs.Tanimilast was used in the study of obstructive lung disease. |
Targets&IC50 | PDE4:0.026±0.006 nM |
In vitro | Methacholine-induced protein expression of smooth muscle-myosin was fully inhibited by CHF-6001 (0.3-100 nM; Guinea pig precision-cut lung slices). CHF-6001 did not affect airway closure and had limited effects on TGF-β1-induced remodeling, but rather, it inhibited methacholine-induced TGF-β release.[2] |
Synonyms | CHF-6001 |
Molecular Weight | 687.54 |
Formula | C30H30Cl2F2N2O8S |
CAS No. | 1239278-59-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tanimilast 1239278-59-1 Metabolism PDE CHF 6001 CHF-6001 CHF6001 inhibitor inhibit